Norifumi Urao, MD/Ph.D.,Pharmacology, PI NIH-NIGMS 3R01GM144624-02S1 Administrative supplement to R01GM144624 09/01/2024 - 08/31/2025
David Auerbach, Ph.D.,Pharmacology, PI NIH-NINDS 3R61NS133273-02S1 Equipment supplement to NIH-NINDS R61/R33 09/01/2024 - 02/28/2025
Juntao Luo, Ph.D.,Pharmacology, PI NIH/NIGMS 3R35GM153495-01S1 Instrument supplement award to NIGMS/R35 09/01/2024 - 02/28/2025
Yamin Li, Ph.D.,Pharmacology, PI Upstate Cancer Center Research Pilot Grant Secondary lymphoid organ-targeting lipid nanoparticles for cancer vaccine development 07/01/2024 - 06/30/2026
Jennifer M. Messina, M.D., Ph.D. Student, Pharmacology PI (sponsor: Luo) F30, NIH GM Targeting Both Hyperinflammation and Pyroptosis Via Nanotherapeutics to Improve Outcomes in Gram-Negative Sepsis award date 07/15/24
Juntao Luo, Ph.D.,Pharmacology, Co-PI 2023-2024 Watson College-Upstate Medical Pilot Research Grant Core-Shell Microparticles with Surface Nanopores and Dissolvable Core for Intrapulmonary Drug Delivery 07/01/2024 - 06/30/2025
Juntao Luo, Ph.D.,Pharmacology, PI Maureen T. O'Hara TEAL THERE's A CURE and Christine Schoeck Blakely Ovarian Cancer Research Fund (award extension) The development of telodendrimer nanotechnology for ovarian cancer treatment and immune modulations 12/01/2018 - 11/30/2024
Juntao Luo, Ph.D.,Pharmacology, PI NIH/NIGMS R35 MIRA Award Bioactive immune-modulating nanodrug for sepsis treatment 05/01/2024 - 02/28/2029
Yamin Li, Ph.D.,Pharmacology, PI Hendricks Pilot Grant Novel cationic lipid nanoparticle enabled head and neck cancer vaccine 01/01/2024 - 12/31/2024
Grants Awarded in 2023
David Auerbach, Ph.D.,Pharmacology, PI NIH R01 Masonic Medical Research Institute From variants to mechanisms for cardiac arrythmias 08/01/2023 - 06/30/2024
Norifumi Urao, M.D., Ph.D.,Pharmacology PI NIH/NIGMS R01 Targeting neutrophil clearance to harness myeloid responses for wound healing 09/01/2023 - 08/31/2025
Hong Lu, Ph.D.,Pharmacology PI HT9425-23-1-0073 DoD Discover Award Novel Drug/receptor codelivery to the liver-lung axis to overcome glucocorticoid resistance and acute respiratory distress syndrome in sepsis 05/01/2023 - 04/30/2025
David Auerbach, Ph.D.,Pharmacology PI Dravet Syndrome Foundation: Clinical Research Grant Genetic Substrates and Physiological Triggers for Autonomic and Cardiac Abnormalities in Dravet Syndrome 01/01/2023 - 12/31/2024
David Auerbach, Ph.D.,Pharmacology PI (Co-PI's: David Auerbach, Inna Hughes) University of Rochester Medical Center CTSI - UNYTE Pilot Wearable Multi-System Recordings for Improved Disease Diagnostics 07/31/2023 - 06/30/2024
Juntao Luo, Ph.D.,Pharmacology, PI PR221368 DoD PRMRP/TTD Award A multimodal nanotrap to alleviate ARDS in traumatic injuries 07/01/2023 - 06/30/2027
David Auerbach, Ph.D.,Pharmacology, PI NIH-NINDS R61/R33 Development of a Genetic Rabbit Model of Kcnh2-Mediated Epilepsy, SUDEP, & Long QT Syndrome Type 2 07/01/2023 - 06/30/2026
Grants Awarded in 2022
Juntao Luo, Ph.D.,Pharmacology, PI SUNY Research Seed Grant Program A novel approach to mitigate perioperative ovarian cancer 12/01/2022-05/30/2024
Juntao Luo, Ph.D.,Pharmacology, Co-PI(PI: Kollisch-Singule, co-PI: Luo) NIH/NHLBI 1 R42 HL166050-01A1 Aerosolized Chemically Modified Tetracycline Nanoformation for the Treatment of ARDS 12/01/2022 - 11/30/2025
Yamin Li, Ph.D.,Pharmacology PI Carol M. Baldwin Research Fund Lipid nanoparticle formulation optimization for breast cancer vaccine development 12/01/2022 - 11/30/2024
Yamin Li, Ph.D.,Pharmacology PI R03 NIH Development of novel lipid nanoparticles for mRNA delivery 05/15/2022 - 02/28/2024
Hong Lu, Ph.D.,Pharmacology, PI SUNY - Upstate Research Pilot Program Novel drug/mRNA co-delivery to the liver-lung axis to overcome glucocorticoid resistance and multiorgan dysfunction syndrome in sepsis 08/01/2022-07/31/2023
Juntao Luo, Ph.D.,Pharmacology, PI SUNY Technology Accelerator Fund An Injectable Nanoformulation of CMT-3 for Sepsis and ARDS Treatment 07/01/2022 - 08/31/2023
Grants Awarded in 2021
Juntao Luo, Ph.D., Pharmacology PI (PI's: Juntao Luo, Rinki Agarwal) Maureen T. O'Hara TEAL THERE's A CURE and Christine Schoeck Blakely Ovarian Cancer Research Fund Establish PDX ovarian cancer models to test novel nanotherapeutics 1/1/2018 - 12/31/2021
David Auerbach, Ph.D., Pharmacology PI Cure Epilepsy Cardiac and autonomic pathological markers for arrhythmias and sudden unexpected death in epilepsy patients 9/01/2021 - 8/31/2022
Grants Awarded in 2020
Juntao Luo, Ph.D., Pharmacology PI NY FIRST/Empire State Development Program Translational Research for a novel Nanotrap hemoperfusion approach for sepsis treatment. 1/1/2020 - 12/31/2024
Juntao Luo, Ph.D., Pharmacology, PI (PI: Luo, Co-PI: Cooney) SUNY - Upstate Research Pilot Program A translational study of a novel nanotrap for sepsis treatment using patient blood samples. 5/1/2020 - 4/30/2021
Grants Awarded in 2019
Hong Lu, Ph.D., Pharmacology PI R21, NIH Natl. Inst. Alcohol Abuse Liver specific glucocorticoid action in alcoholic liver disease 5/1/2019 - 4/30/2021
Ying Huang, M.D., Ph.D., Pharmacology PI Institutional Bridge Grant MGL in lung cancer signaling and therapeutics 6/1/2019 - 5/31/2020
David Auerbach, Ph.D., Pharmacology PI American Heart Association Career Development Award Mechanisms for Arrhythmias and Seizures in Long QT Syndrome 7/1/2018 - 6/30/2021
David Auerbach, Ph.D., Pharmacology PI Central New York Foundation Multi-System Monitoring to Identify Pathological Markers and Mechanisms for Sudden Unexpected Death in Epilepsy 5/1/2019 - 4/30/2020
David Auerbach, Ph.D., Pharmacology PI American Epilepsy Society Junior Investigator Award (Kevin's Fellow) Altered Neuronal Electrical Fundtion in Long QT Syndrome Type 2 7/1/2018 - 6/30/2019
Norifumi Urao, M.D., Ph.D., Pharmacology PI NIH/NIDDK R01 Impact of hematopoietic stem progenitor cell dysfunction on tissue recovery from ischemic injury in metabolic syndrome 8/21/2017 - 7/31/2022
Hong Lu, Ph.D., Pharmacology PI R03, NIH Natl. Cancer Inst. Liver specific glucocorticoid action in liver cancer 7/1/2019 - 6/30/2021
Laura Szczesniak, M.D., Ph.D. Student, Pharmacology PI (sponsor: Wojcikiewicz) F30, NIH GM Mechanism by which Bok binds to IP3Rs and regulates mitochondrial dynamics 8/3/19 - 8/3/22
Juntao Luo, Ph.D.Pharmacology, PI (Luo) 1 R01 GM130941-01 NIH/NIGMS (PI: Luo, J) An innovative hemoperfusion nanotrap for sepsis treatment. 09/20/2018-08/30/2022
Ying Huang, M.D., Ph.D.,Pharmacology, PI Carol M. Baldwin Breast Cancer Research Fund Investigation of RBELIA in human breast cancer 12/1/2018 - 11/30/2020
Grants Awarded in 2017
M. Saeed Sheikh, M.D., Ph.D., Pharmacology, PI Higher Education Commission The International Research Support Initiative Program, February 2, 2017
Richard D. Veenstra, Ph.D., Pharmacology, PI Central New York Community Foundation Molecular and Ionic Mechanisms for Loperamide Overdose Induced Cardiotoxicity, March 1, 2017
Juntao Luo, Ph.D., Pharmacology, PI NYS Department of Health Structure-Based Nanocarrier Design for Targeted Cabazitaxel Delivery in Advanced Breast Cancer Brain Metastases, January 1, 2017 http://upstateonline.info/static/March23-March302017/
Richard D. Veenstra, Ph.D., Pharmacology, PI American Heart Association Acetylation and Modulation of the Cardiac L-type Ca2+ Current by HDAC Inhibitors July 1, 2017 - June 30, 2019
Richard J.H. Wojcikiewicz, Ph.D.,Pharmacology, PI RO1, NIH, NIDDK Mechanism of IP3 receptor processing by the ERAD pathway and analysis of the IP3 receptor-erlin 1/2 complex-RNF170 axis. 07/01/17-05/31/21
Richard J.H. Wojcikiewicz, Ph.D., Pharmacology, PI RO1, NIH, NIGMS Significance of the novel Bok-IP3 receptor interaction. 08/01/17-04/30/21
M. Saeed Sheikh, M.D., Ph.D.,Pharmacology, PI Carol M. Baldwin Breast Cancer Research Fund Development of a natural product for breast cancer treatment 12/1/2017 - 11/30/2019
